Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Spyre Therapeutics Inc (NASDAQ: SYRE) closed the day trading at $12.79 down -8.58% from the previous closing price of $13.99. In other words, the price has decreased by -$8.58 from its previous closing price. On the day, 1.64 million shares were traded. SYRE stock price reached its highest trading level at $13.63 during the session, while it also had its lowest trading level at $12.56.
Ratios:
For a better understanding of SYRE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.26 and its Current Ratio is at 11.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on March 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $27.
On September 04, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 06 ’24 when Albers Jeffrey W. sold 6,700 shares for $36.76 per share. The transaction valued at 246,313 led to the insider holds 27,360 shares of the business.
Albers Jeffrey W. sold 300 shares of SYRE for $10,929 on Oct 25 ’24. The Director now owns 34,060 shares after completing the transaction at $36.43 per share. On Oct 25 ’24, another insider, SESSIONS, LLC, who serves as the Director of the company, bought 7,000 shares for $33.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 770687040 and an Enterprise Value of 323656416.
Stock Price History:
The Beta on a monthly basis for SYRE is 2.79, which has changed by -0.6555346 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, SYRE has reached a high of $40.83, while it has fallen to a 52-week low of $13.88. The 50-Day Moving Average of the stock is -35.50%, while the 200-Day Moving Average is calculated to be -50.40%.
Shares Statistics:
Over the past 3-months, SYRE traded about 649.08K shares per day on average, while over the past 10 days, SYRE traded about 843800 shares per day. A total of 60.26M shares are outstanding, with a floating share count of 51.14M. Insiders hold about 15.13% of the company’s shares, while institutions hold 93.78% stake in the company. Shares short for SYRE as of 1741910400 were 10767640 with a Short Ratio of 16.59, compared to 1739491200 on 9923952. Therefore, it implies a Short% of Shares Outstanding of 10767640 and a Short% of Float of 24.229999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
